The DOI matches its Crossref record; 242 of the 242 references it cites were found in a registry or an index.
The Ubiquitin-Proteasome Pathway and Its Role in Cancer
Abstract
Critical cellular processes are regulated, in part, by maintaining the appropriate intracellular levels of proteins. Whereas de novo protein synthesis is a comparatively slow process, proteins are rapidly degraded at a rate compatible with the control of cell cycle transitions and cell death induction. A major pathway for protein degradation is initiated by the addition of multiple 76–amino acid ubiquitin monomers via a three-step process of ubiquitin activation and substrate recognition. Polyubiquitination targets proteins for recognition and processing by the 26S proteasome, a cylindrical organelle that recognizes ubiquitinated proteins, degrades the proteins, and recycles ubiquitin. The critical roles played by ubiquitin-mediated protein turnover in cell cycle regulation makes this process a target for oncogenic mutations. Oncogenes of several common malignancies, for example colon and renal cell cancer, code for ubiquitin ligase components. Cervical oncogenesis by human papillomavirus is also mediated by alteration of ubiquitin ligase pathways. Protein degradation pathways are also targets for cancer therapy, as shown by the successful introduction of bortezomib, an inhibitor of the 26S proteasome. Further work in this area holds great promise toward our understanding and treatment of a wide range of cancers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–242 of 242
Existence of a molecular ruler in proteasomes suggested by analysis of degradation products
Wenzel, T., Eckerskorn, C., Lottspeich, F., & Baumeister, W. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00665-2 · Cited by 176
Johnson, T. R., Stone, K., Nikrad, M. P., Yeh, T. C., Zong, W., Thompson, C. B., Nesterov, A., & Kraft, A. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206656 · Cited by 173
Control of Enzyme Levels in Mammalian Tissues
Schimke, R. T. (1973) · Advances in Enzymology - and Related Areas of Molecular Biology · doi:10.1002/9780470122822.ch3 · Cited by 166
The von Hippel–Lindau Protein, Vascular Endothelial Growth Factor, and Kidney Cancer
George, D. J., & Kaelin, W. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmp030061 · Cited by 165
Protein Translocation Channels in the Proteasome and Other Proteases
Larsen, C. N., & Finley, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80427-4 · Cited by 164
Schmidt, M. H. H., Furnari, F. B., Cavenee, W. K., & Bögler, O. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1031790100 · Cited by 164
Ganoth, D., Leshinsky, E., Eytan, E., & Hershko, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37771-8 · Cited by 160
The spectrum of mutations in UBE3A causing Angelman syndrome
Fang, P. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.129 · Cited by 159
Neff, N. T., Demartino, G., & Goldberg, A. L. (1979) · Journal of Cellular Physiology · doi:10.1002/jcp.1041010311 · Cited by 158
Casein Kinase 1: A Wnt'er of Disconnect
Polakis, P. G. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00969-7 · Cited by 154
Ichii, S., Takeda, S., Horii, A., Nakatsuru, S., Miyoshi, Y., Emi, M., Fujiwara, Y., Koyama, K., Furuyama, J.-I., & Utsunomiya, J. (1993) · PubMed · Cited by 143
The Mutant p53-Conformation Modifying Drug, CP-31398, Can Induce Apoptosis
Takimoto, R., Wang, W., Dicker, D. T., Rastinejad, F., Lyssikatos, J. P., & El‐Deiry, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.1.41 · Cited by 142
Reiss, Y., Kaim, D., & Hershko, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69123-9 · Cited by 140
Lyapina, S., Correll, C. C., Kipreos, E. T., & Deshaies, R. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7451 · Cited by 139
Pei, X.-Y., Dai, Y., & Grant, S. (2003) · Leukemia · doi:10.1038/sj.leu.2403109 · Cited by 137
Phosphorylation of the Cyclosome Is Required for Its Stimulation by Fizzy/cdc20
Shteinberg, M., Protopopov, Y., Listovsky, T., Brandeis, M., & Hershko, A. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0884 · Cited by 136
BRCA1 RING Domain Cancer-predisposing Mutations
Brzović, P. S., Meza, J. E., King, M., & Klevit, R. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106551200 · Cited by 135
Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1.
Handley, P., Mueckler, M. M., Siegel, N. R., Ciechanover, A. J., & Schwartz, A. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.258 · Cited by 130
Wang, W., Takimoto, R., Rastinejad, F., & El-Deiry, W. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.6.2171-2181.2003 · Cited by 126
Fujiwara, T., Tanaka, K., Orino, E., Yoshimura, T., Kumatori, A., Tamura, T., Chung, C. H., Nakai, T., Yamaguchi, T., & Shin, S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46265-x · Cited by 124
Chiarle, R., Fan, Y., Piva, R., Boggino, H. E., Skolnik, J. M., Novero, D., Palestro, G., Wolf‐Peeters, C. D., Chilosi, M., Pagano, M., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62571-0 · Cited by 111
Structural Features of 26S and 20S Proteasomes
Lupas, A. N., Koster, A. J., & Baumeister, W. P. (2017) · Enzyme and Protein · doi:10.1159/000468684 · Cited by 108
Pub1 acts as an E6‐AP‐like protein ubiquitiin ligase in the degradation of cdc25.
NEFSKY, B., & Beach, D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00472.x · Cited by 108
Molecular cloning and functional analysis of three subunits of yeast proteasome.
Emori, Y., Tsukahara, T., Kawasaki, H., et al. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.1.344 · Cited by 94
Sullivan, M. L., & Vierstra, R. D. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54365-9 · Cited by 89
When protein destruction runs amok, malignancy is on the loose
Pagano, M., & Benmaamar, R. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00243-5 · Cited by 89
Kinetic Aspects of Assembly and Degradation of Proteins
Steinberg, D. H., Vaughan, M. M., & Anfinsen, C. B. (1956) · Science · doi:10.1126/science.124.3218.389 · Cited by 87
p27 in Cell Cycle Control and Cancer
Møller, M. B. (2000) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190009053535 · Cited by 87
Luu, Y., Bush, J., Cheung, K. J., & Li, G. (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5526 · Cited by 86
Elbel, M., Carl, S., Spaderna, S., & Iftner, T. (1997) · Virology · doi:10.1006/viro.1997.8860 · Cited by 82
Deffenbaugh, A. E., Scaglione, K. M., Zhang, L., Moore, J. M., Buranda, T., Sklar, L. A., & Skowyra, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00641-x · Cited by 81
Easwaran, V., Song, V., Polakis, P. G., & Byers, S. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16641 · Cited by 80
Binding Sites of Ubiquitin-Protein Ligase
Reiss, Y., Heller, H., & Hershko, A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81630-1 · Cited by 79
Handley, P., Stephen, A. G., Trausch‐Azar, J. S., Ciechanover, A. J., & Schwartz, A. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)30113-7 · Cited by 77
Molecular Cloning and Expression of a 26 S Protease Subunit Enriched in Dileucine Repeats
Deveraux, Q. L., Jensen, C., & Rechsteiner, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23726 · Cited by 68
Some characteristics of the alanine aminotransferase- and arginase-inactivating system of lysosomes
Haider, M., & Segal, H. L. (1972) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(72)90136-1 · Cited by 66
Mathias, N., Steussy, C. N., & Goebl, M. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.7.4040 · Cited by 60
Sung, P., Prakash, S., & Prakash, L. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80169-u · Cited by 59
Stephen, A. G., Trausch‐Azar, J. S., Ciechanover, A. J., & Schwartz, A. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15608 · Cited by 56
Wingless‐type frizzled protein receptor signaling and its putative role in human colon cancer
Uthoff, S. M. S., Eichenberger, M. R., McAuliffe, T. L., Hamilton, C. J., & Galandiuk, S. (2001) · Molecular Carcinogenesis · doi:10.1002/mc.1039 · Cited by 45
Isoforms of mammalian ubiquitin-activating enzyme.
Cook, J. C., & Chock, P. B. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35767-3 · Cited by 38
Chauhan, D., Li, G., Auclair, D., Hideshima, T., Podar, K., Mitsiades, N., Mitsiades, C. S., Chen, L. B., Munshi, N. C., Saxena, S. P., et al. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000018797.66067.6c · Cited by 31
Cited by
Glioblastoma multiforme: Pathogenesis and treatment
Alifieris, C., & Trafalis, D. T. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.05.005 · Cited by 820
Shibata, T., Ohta, T., Tong, K. I., Kokubu, A., Odogawa, R., Tsuta, K., Asamura, H., Yamamoto, M., & Hirohashi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806268105 · Cited by 728
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies
Nobili, S., Mini, E., Landini, I., Gabbiani, C., Casini, A., & Messori, L. (2010) · Medicinal Research Reviews · doi:10.1002/med.20168 · Cited by 503
UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites
Akimov, V., Barrio-Hernandez, I., Hansen, S. V. F., Hallenborg, P., Pedersen, A.-K., Bekker-Jensen, D. B., Puglia, M., Christensen, S. D. K., Vanselow, J. T., Nielsen, M. M., et al. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0084-y · Cited by 468
Ubiquitin–proteasome system (UPS) as a target for anticancer treatment
Park, J., Cho, J., & Song, E. J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01281-8 · Cited by 408
Metadata
- Authors
- Mani, A., & Gelmann, E. P.
- Venue
- Journal of Clinical Oncology
- Published
- 2005-07-20
- Volume
- 23
- Issue
- 21
- Pages
- 4776-4789
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2033715459
- Cited by
- 549
- References
- 242
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.